Corrigendum: Myotonic Myopathy With Secondary Joint and Skeletal Anomalies From the c.2386C>G, p.L796V Mutation in SCN4A (Frontiers in Neurology, (2020), 11, (77), 10.3389/fneur.2020.00077)

2Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the original article there was a typographical error in the number for the amino acid missense mutation in SCN4A. The correct designation is L796V, which was erroneously transposed as L769V. Corrections have been made in several sections of the paper. The title, which now reads: “Myotonic Myopathy With Secondary Joint and Skeletal Anomalies From the c.2386C>G, p.L796V Mutation in SCN4A.” The Abstract: “The phenotypic spectrum associated with the skeletal muscle voltage-gated sodium channel gene (SCN4A) has expanded with advancements in genetic testing. Autosomal dominant SCN4A mutations were first linked to hyperkalemic periodic paralysis, then subsequently included paramyotonia congenita, several variants of myotonia, and finally hypokalemic periodic paralysis. Biallelic recessive mutations were later identified in myasthenic myopathy and in infants showing a severe congenital myopathy with hypotonia. We report a patient with a pathogenic de novo SCN4A variant, c.2386C>G p.L796V at a highly conserved leucine. The phenotype was manifest at birth with arthrogryposis multiplex congenita, severe episodes of bronchospasm that responded immediately to carbamazepine therapy, and electromyographic evidence of widespread myotonia. Another de novo case of p.L796V has been reported with hip dysplasia, scoliosis, myopathy, and later paramyotonia. Expression studies of L796V mutant channels showed predominantly gainof- function changes, that included defects of slow inactivation. Computer simulations of muscle excitability reveal a strong predisposition to myotonia with exceptionally prolonged bursts of discharges, when the L796V defects are included. We propose L796V is a pathogenic variant, that along with other cases in the literature, defines a new dominant SCN4A disorder of myotonic myopathy with secondary congenital joint and skeletal involvement”.

Cite

CITATION STYLE

APA

Elia, N., Nault, T., McMillan, H. J., Graham, G. E., Huang, L., & Cannon, S. C. (2020, March 20). Corrigendum: Myotonic Myopathy With Secondary Joint and Skeletal Anomalies From the c.2386C>G, p.L796V Mutation in SCN4A (Frontiers in Neurology, (2020), 11, (77), 10.3389/fneur.2020.00077). Frontiers in Neurology. Frontiers Media S.A. https://doi.org/10.3389/fneur.2020.00181

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free